WuXi Biologics stock news

WuXi Biologics stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

16 wire items

2026-10-06 08:53:34 UTC#418063updateconfirmednews

Hang Seng closes 1% higher led by biotech and tech gains; property developers lag

reutersimportance 0.40trust 0.90Hang Seng Index +0.30Hang Seng China Enterprises Index +0.30WuXi Biologics (Cayman) Inc. +0.50+2 entities

2026-10-06 05:04:46 UTC#417178newconfirmednews

Hong Kong stocks rise 0.78% at midday led by biotech and tech gains; property developers lag

reutersimportance 0.40trust 0.80Hang Seng Index +0.30Hang Seng China Enterprises Index +0.30WuXi Biologics (Cayman) Inc. +0.50+2 entities

2026-09-28 09:03:00 UTC#376285newconfirmednews

Global Cell Line Generation Market Projected to Reach USD 2.67 Billion by 2032 at 10.86% CAGR

yahooimportance 0.30trust 0.50Thermo Fisher Scientific Inc. +0.20Lonza Group AG +0.20Merck KGaA +0.20+2 entities

2026-09-24 12:47:00 UTC#362535newconfirmedpress release

WuXi Biologics Wuxi Mashan site passes U.S. FDA GMP inspection

pr newswireimportance 0.40trust 0.90WuXi Biologics (Cayman) Inc. +0.40U.S. Food and Drug Administration +0.30

2026-08-31 08:13:00 UTC#241311newconfirmedanalysis

China Galaxy raises WuXi Biologics target to HK$57.82, cites strong project backlog and revenue visibility

dow_jonesimportance 0.40trust 0.70WuXi Biologics (Cayman) Inc. +0.40China Galaxy International Securities +0.30Vicky Zhu 0+1 entities

2026-08-26 14:59:15 UTC#223800duplicateconfirmednews

WuXi Biologics H1 2026 results confirm 18.4% revenue growth and raised guidance

quartrimportance 0.30trust 0.60WuXi Biologics (Cayman) Inc. +0.60

2026-08-26 13:57:42 UTC#223496duplicateconfirmednews

WuXi Biologics H1 2026 results show 18.4% revenue growth and raised guidance

quartrimportance 0.30trust 0.50WuXi Biologics (Cayman) Inc. +0.60

2026-08-26 12:32:04 UTC#223052newconfirmednews

WuXi Biologics (WXXWY) Releases 2026 Q2 Earnings Presentation

seeking alphaimportance 0.40trust 0.80WuXi Biologics (Cayman) Inc. 0

2026-08-25 12:41:10 UTC#217478duplicateconfirmednews

WuXi Biologics H1 2026 net profit rises 4% on gross margin expansion to 46.2%

reutersimportance 0.30trust 0.90WuXi Biologics (Cayman) Inc. +0.30

2026-08-25 10:01:00 UTC#216558updateconfirmednews

WuXi Biologics (2269.HK) Repurchased 37.1M Shares in 1H 2026

dow_jonesimportance 0.40trust 0.80WuXi Biologics (Cayman) Inc. +0.40

2026-08-25 10:00:00 UTC#216603updateconfirmednews

WuXi Biologics (2269.HK) H1 2026 Revenue Growth Driven by Project Stages and North American Demand

dow_jonesimportance 0.40trust 0.80WuXi Biologics (Cayman) Inc. +0.50

2026-08-25 09:58:00 UTC#216517newconfirmeddata release

Wuxi Biologics 1H 2026 Gross Profit Margin Expands to 46.2% from 42.7%

dow_jonesimportance 0.50trust 0.90WuXi Biologics (Cayman) Inc. +0.40

2026-08-25 09:57:39 UTC#216518updateconfirmednews

WuXi Biologics H1 2026 Revenue Rises 18.4% to RMB 11.8B, Adjusted Net Profit Up 38.4%

quartrimportance 0.60trust 0.70WuXi Biologics (Cayman) Inc. +0.50

2026-08-25 09:57:00 UTC#216523duplicateconfirmednews

WuXi Biologics 1H 2026 Revenue Rises to CNY 11.79B from CNY 9.95B

dow_jonesimportance 0.40trust 0.90WuXi Biologics (Cayman) Inc. +0.40

2026-08-25 09:57:00 UTC#216521updateconfirmeddata release

WuXi Biologics 1H 2026 Net Profit CNY 2.44B vs. CNY 2.34B Year-Ago

dow_jonesimportance 0.40trust 0.90WuXi Biologics (Cayman) Inc. +0.20

2026-07-09 07:31:00 UTC#15946newconfirmedpress release

WuXi Biologics MFG8 Facility Clears FDA Inspection for Commercial Production

pr_newswireimportance 0.50trust 0.90WuXi Biologics +0.50U.S. Food and Drug Administration +0.50MFG8 +0.50